K72
Conditions
Interventions
Group 1: PHLF according to the ISGLS definition—i.e., clinically relevant changes in bilirubin and INR from POD 5 onwards—after elective liver resection were included.
Changes in early postoperative l
Sponsors
Medizinische Fakultät Mannheim, Universität Heidelberg, Universitätsmedizin Mannheim
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Elective liver resection
Exclusion criteria
Exclusion criteria: Emergency liver resections Multivisceral resections
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary endpoint of the study is the occurrence of PHLF as defined by the International Study Group of Liver Surgery (ISGLS). PHLF is defined as a postoperative deterioration in the liver’s synthetic function, reflected by an increase in serum bilirubin and/or INR from postoperative day (POD) 5 onward, compared to previous postoperative values, and considered clinically relevant—i.e., associated with a change in clinical management (e.g., intensified monitoring, pharmacological treatment, or invasive interventions). The ISGLS further classifies PHLF into three grades: Grade A: PHLF without impact on clinical management Grade B: PHLF requiring deviation from the standard postoperative course but manageable without invasive treatment Grade C: PHLF requiring invasive treatment or intensive care management | — |
Secondary
| Measure | Time frame |
|---|---|
| The following secondary endpoints were evaluated: 1. Predictive accuracy (AUC) of bilirubin, INR, AST, and ALT on POD 1–5 for the occurrence of PHLF 2. Optimal cut-off values for AST, ALT, bilirubin, and INR on POD 3 to predict PHLF 3. Trajectory analysis of transaminase levels (AST and ALT) and their association with PHLF 4. Comparison of AST vs. ALT in terms of predictive performance 5. Postoperative length of hospital stay 6. 90-day morbidity and mortality, defined according to Clavien-Dindo and standard definitions 7. Intraoperative blood loss (mL) 8. Operative time (minutes) | — |
Countries
Germany
Contacts
Public ContactSchaima Abdelhadi
Medizinische Fakultät Mannheim, Universität Heidelberg, Universitätsmedizin Mannheim
Outcome results
None listed